JP2025507864A5 - - Google Patents
Info
- Publication number
- JP2025507864A5 JP2025507864A5 JP2024552028A JP2024552028A JP2025507864A5 JP 2025507864 A5 JP2025507864 A5 JP 2025507864A5 JP 2024552028 A JP2024552028 A JP 2024552028A JP 2024552028 A JP2024552028 A JP 2024552028A JP 2025507864 A5 JP2025507864 A5 JP 2025507864A5
- Authority
- JP
- Japan
- Prior art keywords
- gene
- promoter region
- cells
- transgene
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263315579P | 2022-03-02 | 2022-03-02 | |
| US202263315581P | 2022-03-02 | 2022-03-02 | |
| US63/315,581 | 2022-03-02 | ||
| US63/315,579 | 2022-03-02 | ||
| US202363442966P | 2023-02-02 | 2023-02-02 | |
| US63/442,966 | 2023-02-02 | ||
| PCT/US2023/063587 WO2023168341A1 (en) | 2022-03-02 | 2023-03-02 | Engineered cells and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025507864A JP2025507864A (ja) | 2025-03-21 |
| JP2025507864A5 true JP2025507864A5 (cg-RX-API-DMAC10.html) | 2026-03-09 |
Family
ID=87884252
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024552028A Pending JP2025507864A (ja) | 2022-03-02 | 2023-03-02 | 操作された細胞および使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4486870A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2025507864A (cg-RX-API-DMAC10.html) |
| CN (1) | CN119137262A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2023227880A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3253740A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023168341A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117030580B (zh) * | 2023-09-15 | 2024-07-16 | 广州市第一人民医院(广州消化疾病中心、广州医科大学附属市一人民医院、华南理工大学附属第二医院) | LDNs在坏死性小肠结肠炎诊断中的应用 |
| WO2026123001A2 (en) * | 2024-12-06 | 2026-06-11 | Umoja Biopharma, Inc. | Lineage-loci engineered cell therapy and related methods of producing and using same |
| WO2026133125A1 (en) * | 2024-12-16 | 2026-06-25 | Janssen Biotech, Inc. | T cell-specific promoters and methods of use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0716570A4 (en) * | 1993-09-03 | 1997-12-17 | Systemix Inc | Genetically Modified Human Hematopoietic Stem Cells and Their Offspring |
| AU2018301667A1 (en) * | 2017-07-12 | 2020-02-06 | Fundação D. Anna De Sommer Champalimaud E Dr. Carlos Montez Champalimaud Foundation | Methods and systems for conditionally regulating gene expression |
| EP4171616A1 (en) * | 2020-06-26 | 2023-05-03 | Juno Therapeutics GmbH | Engineered t cells conditionally expressing a recombinant receptor, related polynucleotides and methods |
-
2023
- 2023-03-02 JP JP2024552028A patent/JP2025507864A/ja active Pending
- 2023-03-02 WO PCT/US2023/063587 patent/WO2023168341A1/en not_active Ceased
- 2023-03-02 CN CN202380037757.5A patent/CN119137262A/zh active Pending
- 2023-03-02 EP EP23764131.1A patent/EP4486870A4/en active Pending
- 2023-03-02 CA CA3253740A patent/CA3253740A1/en active Pending
- 2023-03-02 AU AU2023227880A patent/AU2023227880A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12024717B2 (en) | Method for reconstructing immune function using pluripotent stem cells | |
| Brown et al. | Derivation of induced pluripotent stem cells from human peripheral blood T lymphocytes | |
| JP2021191294A (ja) | 多能性幹細胞を用いた免疫機能再建法 | |
| EP2841563B1 (en) | Method for developing natural killer cells from stem cells | |
| Zhu et al. | Concise review: human pluripotent stem cells to produce cell-based cancer immunotherapy | |
| US20240180961A1 (en) | Pluripotent stem cell-derived hematopoietic lineages | |
| WO2019106163A1 (en) | Reprogramming of genetically engineered primary immune cells | |
| Guo et al. | Generation and clinical potential of functional T lymphocytes from gene-edited pluripotent stem cells | |
| JPWO2010027062A1 (ja) | B細胞由来iPS細胞およびその用途 | |
| CN115087732B (zh) | 来自人T细胞来源的iPS细胞的细胞毒性T细胞 | |
| US20250368955A1 (en) | B cell lineages derived from pluripotent cells | |
| US20250361487A1 (en) | Natural killer cell lineages derived from pluripotent cells | |
| US20250375520A1 (en) | Production of immune cells | |
| EP4212618A1 (en) | Method of producing vdelta1+ t cells | |
| Xiong et al. | Immune cell generation from human-induced pluripotent stem cells: current status and challenges | |
| KR20250099776A (ko) | 만능 줄기세포 유래 t 세포 집단 및 이의 전구체 | |
| WO2024248157A1 (ja) | 多能性幹細胞由来cd4陽性t細胞、その製造方法及びその用途 | |
| WO2025125443A1 (en) | Production of immune cells | |
| WO2024190905A1 (ja) | Hpv特異的細胞傷害性t細胞のt細胞受容体又はその機能的断片 |